RankAlpha logo
Back to Rankings

ICLR

ICONC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
12
U.S. public peers
Grade Position
In line
vs peer average
ICLR vs peer average
45/100
ICLR vs. peer average (C vs. C)
Grade spread
A 3 · B 2 · C 5 · F 2
Graded peers loaded
Coverage
12 graded
100% of tracked

Peer overview

FTRE is the first available peer comparator.

Fortrea is a direct CRO competitor and is also named in ICON's 2024 Form 20-F competitive set; its margin recovery, book-to-bill, and cancellation trends are relevant for judging whether ICON's issues are company-specific or reflect broader outsourced-development demand pressure [#20F-2024].

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerFTREFortrea
ICLR
ICON
FTRE
Fortrea
Grade
C
A
Momentum
65
96
Value
69
49
Sentiment
25
44
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs FTRE

ICLR / FTRE
Grade Position
In line
ICLR vs. peer average (C vs. C)
45/100
Momentum
65
FTRE
Value
69
ICLR
Sentiment
25
FTRE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ICLR
1
FTRE
FTRE
A
100/100
-2
2
IQV
IQV
C
60/100
Even
3
MEDP
MEDP
C
60/100
Even
4
TMO
TMO
B
80/100
-1
5
MDGL
Madrigal Pharmaceuticals Inc Common
F
20/100
+2
FTRE is the first peer returned for this comparison set.